Change in generic and disease-specific health-related quality of life during a one-year period in patients with newly detected chronic obstructive pulmonary disease

Respiration

Volumn 69, Issue 6, 2002, Pages 513-520

  Tsukino, Mitsuhiro ^a   Nishimura, Koichi ^a   McKenna, Stephen P ^b   Ikeda, Akihiko ^a   Hajiro, Takashi ^a   Zhang, Min ^a   Izumia, Takateru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b GALEN RESEARCH   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Chronic Respiratory Disease Questionnaire; Health related quality of life; Nottingham Health Profile

Indexed keywords

BECLOMETASONE DIPROPIONATE; IPRATROPIUM BROMIDE; PREDNISOLONE; SALBUTAMOL;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; EVALUATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL ISOLATION; TREATMENT OUTCOME;

AGED; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS;

EID: 0036442964     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066456     Document Type: Article

References (26)

1. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar C, Plaza V, Prieto L: Chronic obstructive pulmonary disease stage and health-related quality of life. Ann Intern Med 1997;127:1072-1079.
2. Van Schayck CP, Rutten-van Mölken MPMH, van Doorslaer EKA, Folgering H, van Weel C: Two-year bronchodilator treatment in patients with mild airflow obstruction: Contradictory effects on lung function and quality of life. Chest 1992;102:1384-1391.
3. Van Schayck CP, Dompeling E, Rutten MPMH, Folgering H, van den Boom G, van Weel C: The influence of an inhaled steroid on quality of life in patients with asthma or COPD. Chest 1995;107:1199-1205.
4. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS: Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999;52:187-192.
5. Nocturnal Oxygen Therapy Trial Group: Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980;93:391-398.
6. Mahler DA, Tomlinson D, Olmstead EM, Tosteson ANA, O'Connor GT: Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med 1995;151:61-65.
7. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-778.
8. Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation: The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-1327.
9. Mahler DA, Donohue JF, Barbee RA, Goldman MD, Gross NJ, Wisniewski ME, Yancey SW, Zakes BA, Rickard KA, Anderson WH: Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999;115:957-965.
10. Bernard S, Whittom F, LeBlanc P, Jobin J, Belleau R, Berube C, Carrier G, Maltais F: Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:896-901.
11. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Lonescu AA, Thomas J, Tunbridge J: Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial. Lancet 2000;355:362-368.
12. Ketelaars CA, Abu-Saad HH, Schlosser MA, Mostert R, Wouters EF: Long-term outcome of pulmonary rehabilitation in patients with COPD. Chest 1997;112:363-369.
13. Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NMB, Howard P: Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an out-patient setting. Thorax 1997;52:879-887.
14. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T: Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:785-790.
15. Rutten-van Mölken M, Roos B, Van Noord JA: An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax 1999; 54:995-1003.
16. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
17. Medical Section of the American Lung Association: Standardization of spirometry: 1994 update. Am Rev Respir Dis 1994;152:1107-1136.
18. Japan Society of Chest Disease: The predicted values of pulmonary function testing (in Japanese). Jpn J Thorac Dis 1993;31:appendix.
19. Tsukino M, Nishimura K, Ikeda A, Koyama H, Mishima M, Izumi T: Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 1996;110:896-903.
20. Hunt SM, McEwen J, McKenna SP: Measuring Health Status, Ed 1. London, Croom Helm, 1986.
21. Jaeschke R, Singer J, Guyatt GH: Measurement of health status: Ascertaining the minimum clinically important difference. Control Clin Trials 1989;10:407-415.
22. Redelmeier DA, Guyatt GH, Goldstein RS: Assessing the minimal important difference in symptoms: A comparison of two techniques. J Clin Epidemiol 1996;49:1215-1219.
23. Martin LL: Validity and reliability of a quality of life instrument: The chronic respiratory disease questionnaire. Clin Nurs Res 1994;3:146-156.
24. Jans MP, Schellevis FG, van Eijk JT: The Nottingham Health Profile: Score distribution, internal consistency and validity in asthma and COPD patients. Qual Life Res 1999;8:501-507.
25. Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD: Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis 1987;135:794-799.
26. Harlan LC, Polk BF, Cooper S, Blaszkowski TP, Ignatius SJ, Stromer M, Mull H: Effects of labeling and treatment of hypertension on perceived health. Am J Prev Med 1986;2:256-261.